US advisers endorse single-shot COVID-19 vaccine from J&J

Fda Says J&j 1 Dose Shot Prevents Covid; Final Decision Soon
HONS

FILE - This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday, Feb. 24, 2021, that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration’s scientists confirmed that overall, it's about 66% effective and also said J&J's shot, one that could help speed vaccinations by requiring just one dose instead of two, is safe to use.

WASHINGTON — U.S. health advisers have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that’s expected to provide an easier-to-use option to fight the pandemic.

The panel of Food and Drug Administration experts ruled on Friday that J&J’s vaccine protected against COVID-19 and should be made available for adults.

The FDA is expected to quickly follow the recommendation and make J&J’s shot the third vaccine authorized for emergency use in the U.S. Shipments of a few million doses could begin as early as Monday.

More shots are urgently needed to stay ahead of a mutating virus that has killed more than 500,000 Americans.